Skip to content

Clinical trials

Completed Phase 2 Opioid-Induced Constipation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Induced Constipation Phase: Phase 2 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20072
20091
20103
20116
20142
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)3
Glycyx Therapeutics3
Alkermes, Inc.2
Bausch Health Americas, Inc.2
Shionogi2
Asbjørn Mohr Drewes1
AstraZeneca1
BioGaia Pharma AB1
Centre for Addiction and Mental Health1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Induced Constipation18
Constipation10
Chronic Pain2
Intestinal Diseases2
Neoplasms1
Pain1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.